BPC 157s ability to promote new blood vessel formation, also known as angiogenesis, plays a significant role in its therapeutic effects
The comparison of BPC-157, standard tendon, and ligament treatments is shown in the table below
Every vial is 99.9% HPLC-verified, shipped cold-chain from Canada, with a batch-specific purity report available on request.
cGMP & ISO 5 Benchmarks Grounded in protocol
Furthermore, the beneficial effects of BPC 157 therapy fully involved recovery of the egr-1-gene-implicated pathology (i.e., cardiovascular, liver, and brain) [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40]
Neurocognitive Disorders Abundant data shows that neurocognitive disorders such as dementia or mild cognitive impairment are commonly accompanied by abnormalities of sleep and circadian rhythms